By Mia De Graaf Health Editor For Dailymail.com
Published: 22:57 BST, 16 May 2019 | Updated: 22:57 BST, 16 May 2019
View
comments
US regulators have approved the first blood-thinner for children to treat congenital heart disease, cancer, trauma and infection.
Until now, doctors have been unofficially using adult products to treat kids.
But the US Food and Drug Administration (FDA) has now approved the widely-used injection made by Pfizer, called Fragmin, to be used for pediatric patients over one month old.
'Most children who have VTE are fighting a serious underlying primary illness such as cancer or congenital heart disease,' director of the FDA's Oncology Center of Excellence, Richard Pazdur, MD, said.
'Not only are they fighting a serious illness, having a condition like VTE can then lead to significant complications and even death.'
